Interesting, we found increased ARHGAP21 gene expression in MSCs derived from BM cells of de novo AML patients in comparison with HD and patients with MDS or AML developed after myelodysplasia. This evidence concerns the gene ARHGAP21 and acute myeloid leukemia.